|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Fixed maturities, available-for-sale, at fair value (amortized cost, $3,775,708 and $3,793,777, respectively; allowance for expected credit losses, $4,299 and $4,306, respectively) | ||||||||||||||||||||
| Fixed maturities, trading, at fair value (cost, $13,487 and $14,202, respectively) | ||||||||||||||||||||
| Equity investments, at fair value (cost, $121,742 and $121,766, respectively) | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Business owned life insurance | ||||||||||||||||||||
| Investment in unconsolidated subsidiaries | ||||||||||||||||||||
| Other investments (at fair value, $0 and $1,215, respectively, otherwise at cost or amortized cost) | ||||||||||||||||||||
| Total Investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Premiums receivable, net (allowance for expected credit losses, $7,951 and $7,829, respectively) | ||||||||||||||||||||
| Receivable from reinsurers on paid losses and loss adjustment expenses | ||||||||||||||||||||
| Receivable from reinsurers on unpaid losses and loss adjustment expenses | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Real estate, net | ||||||||||||||||||||
| Operating lease ROU assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Policy liabilities and accruals | ||||||||||||||||||||
| Reserve for losses and loss adjustment expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Reinsurance premiums payable | ||||||||||||||||||||
| Total Policy Liabilities and Accruals | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Debt less unamortized debt issuance costs | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common shares (par value $0.01 per share, 100,000,000 shares authorized, 64,214,694 and 64,020,611 shares issued, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) (net of deferred tax expense (benefit) of ($26,942) and ($21,905), respectively) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury shares, at cost (12,606,968 shares as of each respective period end) | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...
